Marker Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-8.24	-29.93	-41.88	-28.71	-21.43	-147.96	-10.98	-2.46	-34.07	-30.88	Upgrade
Depreciation & Amortization	0	0	3.16	1.08	0.29	0	0	0	0	0	Upgrade
Share-Based Compensation	0.86	3.3	5.96	5.23	5.36	16.35	2.74	1.56	1.71	1.39	Upgrade
Other Operating Activities	-9.06	-0.35	5.47	2.37	-2.5	117.13	-0.2	-5.61	28.02	27.3	Upgrade
Operating Cash Flow	-16.44	-26.97	-27.28	-20.03	-18.28	-14.48	-8.44	-6.51	-4.34	-2.19	Upgrade
Capital Expenditures	0	0	-3.13	-9.25	-0.37	-0.15	0	0	0	0	Upgrade
Other Investing Activities	18.66	-4.95	-	-	-	-	-	-	-	-	Upgrade
Investing Cash Flow	18.66	-4.95	-3.13	-9.25	-0.37	-0.15	0	0	0	0	Upgrade
Share Issuance / Repurchase	1.11	0.2	52.56	6.74	0.82	71.25	5.72	7.83	11.68	1.88	Upgrade
Debt Issued / Paid	0	0	0	0	0	0	0	-0.05	0	0.4	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	-0.91	-	Upgrade
Financing Cash Flow	1.11	0.2	52.56	6.74	0.82	71.25	5.72	7.78	10.78	2.28	Upgrade
Net Cash Flow	3.33	-31.72	22.14	-22.55	-17.84	56.62	-2.72	1.27	6.43	0.09	Upgrade
Free Cash Flow	-16.44	-26.97	-30.41	-29.29	-18.66	-14.63	-8.44	-6.51	-4.34	-2.19	Upgrade
Free Cash Flow Margin	-496.51%	-767.66%	-2449.11%	-6274.32%	-8752.25%	-7100.98%	-4610.10%	-	-	-	Upgrade
Free Cash Flow Per Share	-1.87	-3.23	-3.98	-6.23	-4.09	-7.66	-8.93	-9.45	-11.86	-16.97	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).